Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

"FDA tags Medtronic’s nerve monitoring system recall as Class I" was originally created and published by Medical Device ...

Medtronic beat first-quarter earnings and revenue estimates on strong sales of its medical devices. Sales were higher at the ...

Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...

The hit to demand for spinal devices from deferred procedures pulled down revenue from the neuroscience unit in Q2 2022 ...

Medtronic will host a video webcast at 7:00 a.m. CST on November 19, 2024, to discuss results for its second quarter of full fiscal year 2025. The webcast can be accessed at ...

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based ... continuous glucose monitoring systems, and insulin pump ...

GALWAY, Ireland, Nov. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of ...

For example, Medtronic's continuous glucose monitoring [CGM] systems have taken ... due to their underperformance in the CGM market; the devices that were driving growth get recalled.

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Medtronic, a global leader in healthcare technology, unveiled results from the Prospective Registry for Assessment of Acute ...